Angela Grant Sells 397 Shares of Palomar (NASDAQ:PLMR) Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) insider Angela Grant sold 397 shares of the business’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $122.04, for a total transaction of $48,449.88. Following the sale, the insider directly owned 5,939 shares of the company’s stock, valued at approximately $724,795.56. The trade was a 6.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Palomar Trading Up 0.5%

NASDAQ PLMR traded up $0.63 during trading hours on Monday, hitting $124.22. The company’s stock had a trading volume of 240,836 shares, compared to its average volume of 180,129. The company has a market capitalization of $3.29 billion, a PE ratio of 19.38 and a beta of 0.44. Palomar Holdings, Inc. has a 52 week low of $104.47 and a 52 week high of $175.85. The company’s 50-day simple moving average is $127.67 and its two-hundred day simple moving average is $123.57.

Palomar (NASDAQ:PLMR) last posted its earnings results on Thursday, November 6th. The company reported $2.01 earnings per share for the quarter, beating analysts’ consensus estimates of $1.56 by $0.45. Palomar had a return on equity of 21.93% and a net margin of 22.59%.The company had revenue of $244.66 million for the quarter, compared to analyst estimates of $207.98 million. During the same quarter last year, the company earned $1.23 earnings per share. Research analysts anticipate that Palomar Holdings, Inc. will post 5.99 EPS for the current fiscal year.

Institutional Trading of Palomar

A number of institutional investors have recently modified their holdings of the business. Invesco Ltd. raised its holdings in Palomar by 234.1% during the 2nd quarter. Invesco Ltd. now owns 798,361 shares of the company’s stock valued at $123,147,000 after acquiring an additional 559,383 shares during the period. Alliancebernstein L.P. grew its position in shares of Palomar by 290.2% in the second quarter. Alliancebernstein L.P. now owns 497,080 shares of the company’s stock valued at $76,675,000 after purchasing an additional 369,697 shares in the last quarter. Westfield Capital Management Co. LP raised its stake in shares of Palomar by 81.0% during the 3rd quarter. Westfield Capital Management Co. LP now owns 738,528 shares of the company’s stock valued at $86,223,000 after purchasing an additional 330,592 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Palomar by 72.1% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 785,165 shares of the company’s stock worth $105,809,000 after purchasing an additional 328,993 shares in the last quarter. Finally, AustralianSuper Pty Ltd purchased a new stake in Palomar during the 2nd quarter worth about $37,253,000. 90.25% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar closed the acquisition of The Gray Casualty & Surety Company, expanding its surety capabilities and product mix — a strategic tuck‑in that can add premium, diversify risk exposure and support growth in specialty lines. BCP Completes Sale of The Gray Casualty & Surety Company
• Neutral Sentiment: Palomar will report Q4 and full‑year 2025 results after the close on Feb 11, 2026, with a conference call Feb 12 — an event that typically drives short‑term volume and volatility as investors update estimates and listen for management commentary on reserve development, underwriting margin, and growth. Earnings Release & Conference Call
• Negative Sentiment: Multiple insiders (including the CEO, President, CFO and other senior executives) sold shares on Jan. 29 and Jan. 31, reducing positions by low-single-digit percentages in many cases. Heavy insider selling can signal liquidity taking or tax/comp planning, but it may concern some investors about insider confidence or timing ahead of earnings. Representative coverage of recent insider sales is here. CEO Sells Stock (Example)

Analyst Ratings Changes

PLMR has been the topic of several analyst reports. Wall Street Zen upgraded shares of Palomar from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. JPMorgan Chase & Co. upped their price objective on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Weiss Ratings raised Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Finally, Keefe, Bruyette & Woods increased their price target on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research report on Tuesday, January 6th. Six analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $159.50.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.